Page 2 - Nasdaq Rnlx News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq rnlx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Rnlx Today - Breaking & Trending Today

FDA Grants De Novo Marketing Authorization for

Simple Blood Test Aids Risk Assessment for Approximately 14 Million Eligible Patients in the United States Diabetic Kidney Disease is the Leading Cause of. ....

New York , United States , City Of , United Kingdom , Ignacio Guerrero Ros , James Mccullough , David Schull , Karla Gonye , Icahn School Of Medicine At Mount Sinai , Exchange Commission , Drug Administration , Centers For Disease , Russo Partners , Laboratory Developed Test , Simple Blood Test Aids Risk Assessment , Eligible Patients , Kidney Disease , Leading Cause , End Stage Kidney Disease , Breakthrough Device , Prognostic Test , Chronic Kidney Disease Progression , Laboratory Developed , Icahn School , Mount Sinai , Disease Control ,

Renalytix Plc (NASDAQ:RNLX) Short Interest Update

Renalytix Plc (NASDAQ:RNLX – Get Rating) saw a significant growth in short interest during the month of May. As of May 31st, there was short interest totalling 385,200 shares, a growth of 44.9% from the May 15th total of 265,900 shares. Based on an average trading volume of 46,300 shares, the days-to-cover ratio is currently […] ....

Stifel Nicolaus , Advisor Group , Renalytix Plc , Renalytix Company Profile , Granahan Investment Management , Envestnet Asset Management Inc , Advisor Group Holdings Inc , Get Rating , Stock Down , Asset Management , Investment Management , Group Holdings , State Street Corp , Street Corp , Renalytix Daily , Nasdaq Rnlx , Computer And Technology ,

Renalytix (RNLX) to Release Quarterly Earnings on Friday

Renalytix (NASDAQ:RNLX – Get Rating) is scheduled to issue its quarterly earnings data before the market opens on Friday, June 9th. Analysts expect the company to announce earnings of ($0.13) per share for the quarter. Investors that wish to listen to the company’s conference call can do so using this link. Renalytix (NASDAQ:RNLX – Get […] ....

Renalytix Plc , Jpmorgan Chase Co , Lazard Asset Management , Tejara Capital Ltd , Ci Private Wealth , Renaissance Technologies , Get Rating , Stock Down , Capital Ltd , Asset Management , Renalytix Daily , Nasdaq Rnlx , Computer And Technology ,

Renalytix Plc (NASDAQ:RNLX) Short Interest Down 20.0% in May

Renalytix Plc (NASDAQ:RNLX – Get Rating) was the target of a significant drop in short interest in May. As of May 15th, there was short interest totalling 265,900 shares, a drop of 20.0% from the April 30th total of 332,500 shares. Based on an average daily trading volume, of 40,000 shares, the days-to-cover ratio is […] ....

Pinnacle Associates Ltd , Ci Private Wealth , Tejara Capital Ltd , Lazard Asset Management , Renalytix Plc , Get Rating , Capital Management , Capital Ltd , Asset Management , Renalytix Daily , Nasdaq Rnlx , Computer And Technology ,

Short Interest in Renalytix Plc (NASDAQ:RNLX) Expands By 52.5%

Renalytix Plc (NASDAQ:RNLX – Get Rating) was the target of a significant increase in short interest in April. As of April 15th, there was short interest totalling 308,600 shares, an increase of 52.5% from the March 31st total of 202,300 shares. Based on an average trading volume of 49,800 shares, the short-interest ratio is presently […] ....

Lazard Asset Management , Renalytix Plc , Tejara Capital Ltd , Ci Private Wealth , Pinnacle Associates Ltd , Renalytix Company Profile , Get Rating , Capital Management , Capital Ltd , Asset Management , Renalytix Daily , Nasdaq Rnlx , Computer And Technology ,